RETN and hyperthyroidism: The resistin levels of patients with hyperthyroidism after treatment were significantly lower than those before treatment (MD = 2.16, 95% CI = 1.00–3.32, P < 0.05, I2 = 93%, Pheterogeneity = 0.0003) (Figure 4B).